Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
about
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipientsTacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipientsTacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipientsTacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipientsMetabolic consequences of modern immunosuppressive agents in solid organ transplantationSkin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repairCurrent state of renal transplant immunosuppression: Present and futureDe novo glomerular diseases after renal transplantationUse of monoclonal antibodies in renal transplantation.A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy.Transplantation immunology: solid organ and bone marrow.PharmGKB summary: cyclosporine and tacrolimus pathwaysDoes reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and WalesAssociation of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipientsPrevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil.Comparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programmeNew-onset diabetes after renal transplantation: risk assessment and management.Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled TrialComparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival.Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.Predictors of new onset diabetes after renal transplantation.Need for quality improvement in renal systematic reviews.The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects.The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvementPancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantationUncertainty in heterogeneity estimates in meta-analyses.Renal Transplantation: Experience at a Single Centre.Secreted klotho and chronic kidney diseaseDaclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis.Influence of tacrolimus metabolism rate on renal function after solid organ transplantation.Current immunosuppressive treatment after kidney transplantation.The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
P2860
Q24187213-054F0C31-04FF-4965-A3CB-D0F86A5E8056Q24202759-AD3C8B25-7A1A-4070-99C9-8B5DB813B91AQ24236783-98423153-391B-4046-A91F-6BB46A6726DEQ24245456-C19DB799-1EB3-46D8-8548-327AE2642665Q26746936-E34027A3-4F01-4D0E-B868-2F652F282E93Q26822549-05947FFA-CBAE-4D07-96CF-FC44DAE3F1FAQ26829789-40D30A79-E633-486B-982E-28B358156C81Q27005877-B08AEA5C-FD3D-4429-91D2-AF225DEB97AAQ33396236-E40C8A33-195A-4543-924A-8A086039C11CQ33713776-DA4B404E-8F42-4B3B-9959-F6D8264C4B81Q33803804-8069974B-7629-461B-B28B-A727CDF39923Q33989902-AF992CC0-2C63-488B-8FDF-DA56B5305AD4Q34365272-05E3C438-406C-4126-BCE3-357363E06948Q34482491-901974D9-D8C1-406F-954A-FB856EF17016Q34769696-7683ABF1-D01B-47E8-9056-E2E2578EC6A6Q35026687-D188135B-6FF9-48B9-906D-ECD0D6436D76Q35281597-EC94EE44-5248-4F31-8A58-774656BF7811Q35351287-F4E2CAAC-7582-47D5-9463-AC5DCD23CDAEQ35620221-1EC4A274-84E6-46AA-9A65-4B48718217DCQ35744912-FA9C7E1D-539F-4201-A350-7D0086B7916FQ35993866-2CC8A6F4-5761-4F97-B240-22028BD1AA30Q36423616-A4295CFF-66C0-4AD1-A948-3EFA0CAADF01Q36514864-9ABCA197-379C-4E41-B04A-1488CCCCAE6CQ36530398-1EC12FC6-6539-423B-BEB5-6280ED6840D7Q36736407-53EA3F68-D761-4AC4-B41D-BB28DE7905FDQ36736617-3360540C-399C-40EF-A807-5DD14FEEED8BQ36742537-C6AF8311-9CE4-44E7-87E4-3FE05531EFB2Q36742552-5A78A4E6-A809-4420-AE6C-8CC2501D0658Q36806621-19A55929-9D1A-44D2-8C44-B0F858639A04Q36922829-86E2541B-D573-452F-AEF6-45231C56FE7AQ36942158-802F0CF8-543B-4666-903A-339321C9AEC0Q36987539-C68E0C13-5873-41D5-9298-8F471051367AQ37039029-EDA06F14-D795-45EE-9C8B-824F0AF29D7BQ37190542-DD49C427-A10B-4AC6-A288-8F37D83329BFQ37211151-7A8D7DCC-2D13-40AD-8FBB-037B4C5A68E1Q37277272-74794E65-3F93-488A-8A0D-1AF1211A8ADFQ37280007-878F523A-9D3F-4BD0-BD76-F8AC98CB9126Q37662992-41AA49BD-1E3A-4EF6-B41E-453546566218Q37834028-D2C427E8-9402-45E8-98D5-63AB03C52585Q37877294-08465026-2FA1-4748-835C-8BF1745FB0E4
P2860
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@ast
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@en
type
label
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@ast
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@en
prefLabel
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@ast
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@en
P2093
P2860
P1433
P1476
Tacrolimus versus ciclosporin ...... ssion of randomised trial data
@en
P2093
Jeremy R Chapman
Rebecca C Woodroffe
Rod S Taylor
P2860
P356
10.1136/BMJ.38569.471007.AE
P407
P577
2005-09-12T00:00:00Z